Term Sheet Review — Investor Side

Use when reviewing a VC or angel investor term sheet from the investor's perspective. Flags gaps in downside protection, control rights, information access, and founder accountability. Covers liquidation preference adequacy, anti-dilution minimums, board composition, protective provisions, pay-to-play, founder vesting and IP assignment, exclusivity, and deal-killer scenarios. Applies MENA and international VC market standards (DIFC, ADGM, KSA, US, UK).

Term Sheet Review — Investor Side

When to use this

Use when a VC fund, family office, or angel investor needs to review a term sheet (whether drafted by them or by the company's lawyers) from the investor's perspective. The investor's goals are: downside protection (liquidation preference, anti-dilution), governance rights (board seat, protective provisions, information rights), accountability mechanisms (founder vesting, IP assignment), and exit alignment (drag-along, ROFR, co-sale).

For the founder-side perspective, use [[review-term-sheet-founder-side]].

Inputs

InputWhy it mattersDefault
Term sheetFull documentRequired
Investment stageSeed, Series A, B — calibrates market standardAsk if unclear
Investment size and target ownershipDetermines whether protective provisions match stakeFrom term sheet
JurisdictionCompany registration jurisdiction affects enforceabilityFrom term sheet
Prior roundsExisting cap table and any senior security holdersAsk if available

Review Methodology

1. Liquidation Preference — Adequacy

The liquidation preference determines investor return in a sale, wind-down, or distribution event.

Minimum acceptable: 1× non-participating — investor gets back invested capital (or pro-rata proceeds if higher) before any distribution to common. This is the market floor for institutional investors.

Stage-appropriate expectations:

StageAcceptable preference
Pre-seed / angel1× non-participating is standard; sometimes 1.25× or 1.5× for high-risk early cheques
Seed1× non-participating; some seed investors negotiate participating with 2× cap
Series A / B1× non-participating is strong market standard; participating is increasingly rare
Late stage (distressed)1× or 2× participating may be appropriate given risk profile

Flag:

  • 1× non-participating with no cap on distribution proceeds — investor misses growth upside in a pure exit scenario; check whether preferred converts to common for IPO/high-value exits (standard)
  • Liquidation preference applies on IPO — generally unacceptable; preferred should convert to common upon IPO

2. Anti-Dilution — Minimum Standard

Acceptable minimum: broad-based weighted-average anti-dilution. Any round that provides less protection than this is a deal-killer for institutional investors.

What to verify:

  • Is the formula clearly specified? (Not just "weighted average" — verify it is "broad-based weighted average" incorporating all shares outstanding including option pool)
  • Are carve-outs appropriate? (Anti-dilution should not be triggered by: option pool shares; conversion of existing convertible notes; shares issued as M&A consideration; certain lender warrants)
  • Is the anti-dilution protection automatically applied or does it require shareholder approval? (Auto-apply is investor-protective)

Red flag: company proposing a narrow-based weighted-average (only shares of the same series) — provides less protection than broad-based. Reject.

3. Board Composition

Minimum for lead investor (Series A, 15–30% ownership):

  • 1 board seat for the lead investor
  • Observer right (no voting) for follow-on investors or co-investors who did not lead

Acceptable early-stage structure:

  • 2 founder seats
  • 1 investor seat
  • 1 independent seat (investor has meaningful role in independent director selection)

Flag:

  • No board seat for the lead investor on a significant round — unacceptable for institutional Series A+
  • Independent director can be removed by founder majority without investor consent — weakens governance
  • No mechanism for investor to appoint additional board members as investor's ownership percentage grows (e.g., if anti-dilution triggers additional shares)

4. Protective Provisions — Coverage

Protective provisions are investor veto rights over specific company actions. A complete list for institutional investors:

Core protective provisions (non-negotiable):

  • Sale of the company (merger, acquisition, asset sale, change of control)
  • Issuance of any new class of security ranking senior to or pari passu with investor's preferred series
  • Amendment to articles/charter that adversely affects the investor's preferred series
  • Taking on financial indebtedness above a specified threshold (typically USD 500K to USD 2M depending on stage)
  • Any material change in the nature of the company's principal business
  • M&A transactions above a specified value
  • IPO or public listing (to protect investor's preferences / conversion mechanics)

Additional protective provisions (common but often negotiated):

  • Issuance of any new equity beyond the reserved option pool
  • Entry into any joint venture or partnership
  • Licensing of core IP on an exclusive basis
  • Related-party transactions above a defined threshold

Flag:

  • Protective provisions that require a simple majority of preferred to exercise — should require the lead investor's specific consent to avoid being overridden by small holders of preferred
  • Missing any of the core provisions above
  • Protective provisions that sunset after a defined period (unusual; flag)

5. Information Rights

Investors need visibility into the company's performance to manage their portfolio and meet their own fund reporting obligations.

Standard investor information rights:

RightFrequencyNotes
Management accounts / financialsMonthlyP&L, cash position, KPIs
Annual audited financial statementsAnnuallyRequired by most LP agreements
Annual budget and operating planAnnually before fiscal year startRight to provide input; not right to approve
Notification of material eventsPromptlyLitigation, regulatory action, loss of major customer
Access to management teamReasonableFor due diligence follow-up; not unrestricted
Cap table and option pool updatesOn any changeInvestor needs to track dilution

Flag:

  • Monthly management accounts absent — investor is flying blind
  • Information rights limited to annual audited accounts only — inadequate for active portfolio management
  • Budget review right absent — investor cannot anticipate cash needs or track against plan
  • No notification obligation for material events (litigation, regulatory action, insolvency risk)

MENA context: Gulf-based family offices may be less demanding on monthly management accounts; institutional GPs and LPs expect them. Calibrate against fund type.

6. Pro-Rata Rights

The right to participate in future funding rounds to maintain ownership percentage.

Standard: pro-rata right through at least Series B (or through all rounds for lead investors).

Variants:

  • Super pro-rata: right to invest more than one's ownership percentage in future rounds — often contested by founders
  • Pro-rata notification requirement: company must notify investor of forthcoming round sufficiently in advance for investor to participate

Flag: no pro-rata right at all for a meaningful ownership stake investor — creates unacceptable dilution risk.

7. Pay-to-Play

Pay-to-play provisions require existing investors to participate in follow-on rounds (at least pro-rata) or face consequences:

  • Light pay-to-play: preferred converts to common (loses economic preference) if investor does not participate
  • Heavy pay-to-play: preferred converts to ordinary shares and loses all protective provisions and board rights

Investor's perspective:

  • Pay-to-play is acceptable as a company-protection mechanism to ensure pro-rata participation from early investors in difficult rounds
  • However, investor should ensure the pay-to-play trigger has a minimum round size threshold (does not apply to small bridge rounds or insider rounds)
  • Ensure there is a 30-60 day notice period before the pay-to-play obligation crystallizes

8. Drag-Along — Investor Alignment

Minimum drag-along structure from investor's perspective:

  • Investor (as preferred holder) is part of the majority that can trigger drag-along
  • Drag-along applies to all shareholders including founders (prevents a minority of founders blocking a value-creating exit)
  • Drag threshold: majority of preferred + majority of common + board approval (prevents investor dragging without board support)

Flag:

  • No drag-along at all — founders can block a sale that the investor wants
  • Drag-along requires all-holders consent — unanimity is unworkable for exits
  • Drag threshold set so high that it is practically unusable (e.g., 90% of all shares)

9. Founder Vesting and IP Assignment

Required from investor's perspective:

  • Founder vesting: 4-year, 1-year cliff; unvested shares subject to company repurchase right at cost if founder departs without cause. This protects the company (and therefore investors) from a founder walking away with a large unearned equity stake.
  • Double-trigger acceleration: acceptable; single-trigger acceleration is a red flag — means a founder gets full equity on any acquisition regardless of whether they continue post-CiC
  • IP assignment: all founders must have assigned all company-related IP to the company, including pre-incorporation work and work done on personal equipment. A missing IP assignment can affect the company's ability to raise future rounds or achieve a clean exit.

Flag:

  • No founder vesting (founders already fully vested pre-investment) without a vesting restart on acceptable terms
  • Single-trigger acceleration on CiC — investor pays for future value; founder captures it on day one of a CiC
  • IP assignment incomplete or missing

10. Exclusivity, Fees, and Longstop

Standard:

  • Exclusivity: 30–60 days; should not exceed 90 days without milestone-based extension
  • Legal fees: company pays investor's legal fees up to a cap (USD 25–50K for Series A; USD 75–150K for Series B+)
  • Longstop: if definitive documents are not signed within 90 days of term sheet, term sheet expires

Flag:

  • No longstop date — deal drags indefinitely, investor is in limbo
  • No legal fee reimbursement — unusual for institutional investors
  • Exclusivity with no termination right for investor — investor cannot exit the process if diligence reveals problems

Deal Killers — Walk-Away Scenarios

IssueWhy it is a deal-killer
No founder vestingInvestor is funding founders who can walk away fully vested immediately
Full ratchet anti-dilution offered to existing holders senior to this roundInvestor's new money may trigger catastrophic dilution from existing full-ratchet holders
IP chain of title brokenCompany may not own its core assets
No protective provisions at allInvestor has no governance control over material company decisions
Founders hold a blocking minority on all key votesInvestor cannot enforce any governance rights

Output Format

{
  "findings": [
    {
      "provision": "<section>",
      "issue": "<description>",
      "severity": "critical|high|medium|low",
      "market_standard": "<benchmark>",
      "recommended_redline": "<what investor should push for>"
    }
  ],
  "deal_killers": ["<list of walk-away issues>"],
  "overall_investor_protection": "strong|adequate|weak|unacceptable",
  "priority_redlines": ["<ranked negotiation priorities>"]
}

Related Skills

  • [[review-term-sheet-founder-side]]
  • [[review-msa-deep-review]]
  • [[review-unusual-terms-detector]]
  • [[draft-sha]]
  • [[draft-safe-note]]
  • [[review-ip-ownership-clarity]]

Last updated: October 13, 2026

Files (2)

Jurisdiction
General
Practice area
Corporate
License
MIT
Author
sboghossian
Source
general/corporate/skills/review-term-sheet-investor-side-sboghossian

Test Term Sheet Review — Investor Side

Ask a legal question — get an answer generated live from this skill’s instructions.

Sign in to test this skill.